DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

Q3 2020 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Flynn Management LLC, Its general partner and James E. Flynn - Managing Member
Location
New York, NY
Holdings as of
September 30, 2020
Value $
$4.11B
Num holdings
105
Date filed
12/30/2020, 04:23 PM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q2 2020 - Aug 14, 2020
Next filing
Q4 2020 - Feb 16, 2021
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2020 Q3 - Restatement compared to 2020 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
James E. Flynn Managing Member New York, New York 12/30/2020

This amendment is being filed to correct the market value for Windtree Therapeutics Inc. and the total market value of 13F securities held by the Institutional Investment Manager.

Other Included Managers (1):

Num Name Location File Number
1 Flynn Management LLC New York, NY 028-11827